Cipla JV Gets Process Patent for Stem Cell Drug From Japan – NDTV
Livemint |
Cipla JV Gets Process Patent for Stem Cell Drug From Japan
NDTV New Delhi: Drug major Cipla on Monday said its joint venture firm Stempeutics Research has received a process patent from the Japan Patent Office for novel stem cell drug Stempeucel aimed at treatment of critical limb ischemia (CLI). "The new patent … Stempeutics receives Japan process patent for its stem cell drug 'Stempeucel' Stempeutics gets process patent from Japan for stem cell-based drug Stempeutics receives Japan process patent for its novel stem cell drug … |
